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Abstract Transcription factors (TFs) operate by the combined activity of their DNA-binding
domains (DBDs) and effector domains (EDs) enabling the coordination of gene expression on a
genomic scale. Here we show that in vivo delivery of an engineered DNA-binding protein
uncoupled from the repressor domain can produce efficient and gene-specific transcriptional
silencing. To interfere with RHODOPSIN (RHO) gain-of-function mutations we engineered the ZF6-
DNA-binding protein (ZF6-DB) that targets 20 base pairs (bp) of a RHOcis-regulatory element (CRE)
and demonstrate Rho specific transcriptional silencing upon adeno-associated viral (AAV) vector-
mediated expression in photoreceptors. The data show that the 20 bp-long genomic DNA
sequence is necessary for RHO expression and that photoreceptor delivery of the corresponding
cognate synthetic trans-acting factor ZF6-DB without the intrinsic transcriptional repression
properties of the canonical ED blocks Rho expression with negligible genome-wide transcript




Transcription factors (TFs) operate by entangling their DNA-binding and transcriptional activation or
repression functions (Ptashne, 2014). However, in eukaryotes TF DNA binding and effector activities
are typically structurally modular (Brent, 1985) consisting of a DNA-binding domain (DBD) control-
ling the TF topology on genomic targets and an effector domain (ED) (Brent, 1985; Kado-
naga, 2004) that recruits co-activator or co-repressor complexes (Malik and Roeder, 2010;
Perissi et al., 2010) resulting in either transcriptional activation or repression of gene regulatory net-
works (GRNs) (Neph et al., 2012). Engineered TFs mimic the design of natural TFs (Pavletich and
Pabo, 1991; Beerli and Barbas, 2002). To generate target specificity the DBD module is engi-
neered to recognize unique genome sites (Beerli and Barbas, 2002), whereas the transcriptional
activation or repressor properties are conferred by the selection of the ED (Konermann et al.,
2013). To silence gain-of-function mutations, while studying the features of genomic DNA-TF inter-
actions, here we investigated the hypothesis that engineered DNA-binding proteins without canoni-
cal ED activity possess transcriptional repression properties. As a transcriptional repression target
we selected the G-protein-coupled Receptor Rhodopsin (RHO) gene whose gain-of-function muta-
tions are those most commonly associated with autosomal dominant retinitis pigmentosa (adRP), an
incurable form of blindness (Dryja et al., 1990).
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We generated a DNA-binding protein targeted to a cis-regulatory element (CRE) of the human
proximal RHO promoter region by deconstructing an engineered TF (synthetic) composed of a DBD
(ZF6-DNA-binding protein, ZF6-DB) and the ED (Kruppel-associated box, KRAB repressor domain,
KRAB), which we have shown to be effective in repressing specifically the human RHO transgene car-
ried in an adRP mouse model (Mussolino et al., 2011a). The deletion of the ED resulted in a protein,
ZF6-DB targeting 20 base pairs of genomic CRE, here named ZF6-cis, found at -84 bp to -65 bp
from the transcription start site (TSS) of the human RHO gene (Figure 1a; Mitton et al., 2000).
Genomic ZF6-cis is without apparent photoreceptor-specific endogenous transcription factor-bind-
ing sites (TFBS; Figure 1a), as reported (Kwasnieski et al., 2012). To study the CRE features of ZF6-
cis that ZF6-DB would interfere with upon binding in the absence of KRAB-mediated co-repressor
recruitment, we deleted the 20 bp genomic ZF6-cis sequence and assessed its function by eGFP
reporter assay (Kwasnieski et al., 2012) in living porcine retina by AAV delivery. The 776 bp-long
RHO promoter fragment carrying the ZF6-cis deletion upstream of the eGFP reporter gene (AAV-
RHO-cis-del-EGFP), after delivery to the porcine retinal photoreceptor, showed loss of eGFP expres-
sion compared to the control vector (AAV-RHO-EGFP) (Figure 1b,c). This suggests that ZF6-cis CRE
is necessary for RHO expression (at least for the 776 bp region used in the assay) and that binding
of the synthetic ZF6-DB trans-acting counterpart of ZF6-cis, may indeed repress RHO transcription.
Chromatin immunoprecipitation (ChIP) experiments to evaluate binding to the ZF6-cis target
genomic sequence showed occupancy by the DNA-binding protein ZF6-DB (Figure 1—figure sup-
plement 1b). To evaluate whether ZF6-DB represses transcription of the RHO gene in a physiologi-
cal genomic context, we used the porcine retina (Mussolino et al., 2011b), which shares 19 out of
20 DNA bp with the human genomic ZF6-cis sequence (Figure 1—figure supplement 1a). Subreti-
nal delivery of a low AAV8 vector dose (1x1010 genome copies; gc) of ZF6-DB (AAV8-CMV-ZF6-DB)
resulted in a 45% decrease of porcine Rho transcript levels at 15 days post-injection (Figure 1d).
Immunofluorescence analysis showed depletion of Rho protein and consequent collapse of the rod
outer segments in ZF6-DB positive cells (Figure 1e,f). Despite the lack of detectable Rho expression
eLife digest Proteins called transcription factors bind to sections of DNA known as regulatory
elements to activate or deactivate nearby genes. In animals, transcription factors typically have two
sections: a “DNA-binding domain” that attaches to DNA, and an “effector domain” that is
responsible for interacting with other proteins to regulate the gene’s expression.
Rhodopsin is a gene that encodes the instructions needed to make a light-sensitive protein in the
eyes of humans and other animals. Botta et al. have now used this gene as an example to
investigate whether proteins that contain a DNA-binding domain – but not an effector domain – can
repress gene expression.
The experiments show that only a small section of the regulatory elements in the human
Rhodopsin gene is actually required for the gene to be expressed. Botta et al. designed an artificial
protein – referred to as ZF6-DB – that is able to bind to this section of DNA. The binding of ZF6-DB
to this short DNA section was sufficient to switch off a Rhodopsin gene in living pig cells, and, unlike
conventional transcription factors, seemed to have minimal impact other genes.
Next, Botta et al. used a virus to insert both the gene that encodes ZF6-DB and a normal copy of
Rhodopsin into pigs. In these animals, ZF6-DB switched off the existing copy of Rhodopsin, but not
the inserted copy so the cells produced a working form of the light-sensitive protein. Further
experiments were carried out in mice that have both a faulty version and a normal copy of the
Rhodopsin gene. ZF6-DB switched off the faulty Rhodopsin gene, which allowed the normal
Rhodopsin gene to work without any interference from the faulty copy.
Mutations in Rhodopsin can cause an eye disease that leads to severe loss of vision in humans.
These new findings could now guide future efforts to develop treatments for people with this
condition. It will also be important to investigate how ZF6-DB binds to the regulatory elements in
the Rhodopsin gene and whether a similar strategy could be used to alter the expression of other
genes.
DOI: 10.7554/eLife.12242.002
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Figure 1. Delivery of ZF6-DB DNA-binding synthetic trans-acting factor targeted to a 20 bp of RHO cis-acting regulatory element (CRE) dramatically
reduces Rho expression in photoreceptors. (a) Schematic representation of the chromosomal location of the RHO locus and its proximal promoter
elements indicating the transcription start site (in green, +1) and the location of ZF6-DB binding site (in red, ZF6-Cis) and ZF6-DB (based on Mitton et
Al., 12); BAT1, Bovine A/T-rich sequence1; NRE, NRL response element; TBP, TATA box binding protein. (b) qReal Time PCR of mRNA levels (2̂-DCT) on
the adult porcine retina 15 days after vector delivery of either AAV8-hRHO-eGFP (n=2) or AAV8-hRHO-cis-del-eGFP (n=2) subretinally administered at a
dose of 1x1010, showed that AAV8-hRHO-cis-del-eGFP resulted in decreased transduction (about fifty fold) compared with hRHO. (c) Histology
confirmed the decrease of eGFP expression in hRHO-cis-del-eGFP injected retina compared with the retina injected with hRHO-eGFP. Scale bar,
50 mm. (d) qReal Time PCR of mRNA levels (2̂-DCT) of adult porcine retina injected subretinally with AAV8-CMV-ZF6-DB (n=6) at a vector dose of 1x1010
genomes copies (gc) compared with non-transduced area (n=7) of the same eye 15 days after vector delivery, resulted in robust transcriptional
repression of the Rho transcript. pRHO, porcine Rhodopsin; Gnat1, Guanine Nucleotide Binding Protein1. (e) Rho Immunofluorescence (green)
histological confocal analysis of AAV8-CMV-ZF6-DB treated porcine retina compared with non-transduced area. Scale bar, 100 um. The treatment with
ZF6-DB determined collapse of the outer-segment (OS) with apparent retention of nuclei (stained with DAPI) in the outer nuclear layer (ONL). (f)
Immunofluorescence triple co-localization staining of porcine retina shown in (b) with Rho (blue), rod specific protein Gnat1 (green) and HA (ZF6-DB,
red) antibodies. White arrows indicate co-localization of both HA-tag-ZF6-DB and Gnat1 rods depleted of Rho, whereas yellow arrows showed residual
Rho and Gnat1 positive cells lacking ZF6-DB. A magnification of the triple staining (box) is highlighted. Scale bar, 100 mm. OS, outer segment; IS, inner
segment; ONL, outer nuclear layer; INL, inner nuclear layer. (g) Representative fluorescence-activated cell sorting (FACS) of porcine retina 15 days after
injections of either AAV8-GNAT1-eGFP (dose 1x1012 gc) or co-injection with both AAV8-GNAT1-eGFP and AAV8-CMV-ZF6-DB (dose of eGFP, 1x1012
Figure 1 continued on next page
Botta et al. eLife 2016;5:e12242. DOI: 10.7554/eLife.12242 3 of 14
Short report Human biology and medicine Neuroscience
in most of the transduced rods, rows of photoreceptor nuclei were preserved from degeneration at
this time point (Figure 1e). To further evaluate the extent of Rho silencing in rod photoreceptors by
ZF6-DB, we performed FACS analysis on eGFP-labelled rod cells. Rod cells were isolated from por-
cine retina that had received a subretinal injection of an AAV vector encoding eGFP under the con-
trol of a rod-specific promoter (human Guanine Nucleotide Binding Protein1, GNAT1 promoter
elements (Lee et al., 2010); AAV8-GNAT1-eGFP; dose 1x1012 gc) with or without the vector encod-
ing ZF6-DB (5x1010 gc). Fifteen days after injection, the retina were disaggregated and FACS-sorted.
The retina co-transduced with eGFP and ZF6-DB vector showed virtually a ’somatic knock-out’ of
Rho expression (~85% decrease of Rho transcript levels; Figure 1g,h).
To evaluate genome–wide transcriptional specificity, we analyzed the porcine retinal transcrip-
tome by RNA sequencing (RNA-Seq) from retina harvested 15 days after subretinal injection of the
AAV8 vector encoding ZF6-DB (Figure 2). For comparison we used the engineered TF with the ED,
KRAB (AAV8-CMV-ZF6-KRAB). The low vector doses delivered to the porcine retina (1x1010 gc)
resulted in about twenty-fold lower expression levels of the ZF6-DB and ZF6-KRAB transgenes com-
pared to Crx and Nrl, two retina-specific TFs (Swaroop et al., 2010) (Figure 2a). Of note, despite
these low expression levels, we observed robust Rho transcriptional repression (Figure 2b). We then
analyzed the transcriptional perturbation in response to the AAV retinal gene transfer of ZF6-DB by
determining the differentially expressed genes (DEGs). Remarkably, in vivo the ZF6-DB protein gen-
erated about ten-fold less transcriptional perturbation compared with the ZF6-KRAB protein (19 vs.
222 DEGs; Figure 2e). Notably, this magnitude of perturbation is twenty five-fold lower than that
induced by the ablation of an endogenous rod-specific TF (NRL, 500 DEGs vs 19 DEGs, ZF6-DBD;
[Roger et al., 2014]). Retinal-specific pathway analysis of DEGs showed that ZF6-DB–induced down-
regulation is restricted to the Rho biochemical interactor Gnat1 (Palczewski, 2012), and the up-reg-
ulation of 2 genes associated with acute phase inflammatory response, alpha-2-macroglobulin (A2m)
and glial fibrillary acidic protein (Gfap) (Figure 2c). ZF6-KRAB induced the de-regulation of 17 retinal
network associated genes (Figure 2—figure supplement 1). These results suggest that both ZF6-
DB and the consequent Rho down-regulation marginally interferes with photoreceptor specific path-
ways, apart from Gnat1 repression, and that the up-regulation of the inflammatory response genes
may be due to the collapse of the retinal scaffold caused by Rho depletion. The intersection of reti-
nal transcriptome changes between ZF6-DB and ZF6-KRAB showed that both drive similar perturba-
tion in the expression of 16 genes, which represent 84% of the entire pool of ZF6-DB DEGs
(Figure 2e). Consistently, both ZF6-DB and ZF6-KRAB generated similar functional effects, i.e. con-
cordant up- or down- differential expression of these 16 shared genes (Figure 2d). These results
suggest that both ZF6-DB and ZF6-KRAB bind to similar genomic targets. We next studied whether
the differential transcriptional repression induced by ZF6-DB and ZF6-KRAB was due to similar bio-
chemical binding properties for the ZF6-cis DNA target. Both ZF6-DB and ZF6-KRAB proteins bind
the ZF6-cis RHO DNA target site with similar affinities (Figure 2—figure supplement 2). These data
suggest that, despite the presence of an active canonical repressor domain, ZF6-KRAB generated
Rho silencing by DNA binding. Indeed, ZF6-DB, being exclusively a DNA-binding protein identical
to the DBD of ZF6-KRAB, showed similar Rho silencing effects but far less retinal transcriptional per-
turbations. This indicates that the specificity is conferred by both the engineered design of the
DNA-binding on a genome-specific target (Beerli and Barbas, 2002) and the lack of the ED. In addi-
tion, this finding supports the notion that that ZF6-cis CRE is necessary for Rho expression genome-
wide.
Figure 1 continued
gc; ZF6-DB dose 5x1010 gc). eGFP positive sorted cells (AAV8-GNAT1-eGFP) corresponded to 17,3% of the analysed population (left panel; P2 area,
green dots), whereas, 22,4% of eGFP positive cells in the retina that received both vectors (AAV8-GNAT1-eGFP and AAV8-CMV-ZF6-DB; right panel; P2
area, green dots). (h) qReal Time PCR on sorted rods treated with AAV8-GNAT1-eGFP (n=3) and AAV8-CMV-ZF6-DB (n=3) showed a repression of
about 85% of total rhodopsin when compared with rods treated with eGFP (mRNA levels: 2̂-DCT). Error bars, means +/- s.e.m. n =; *p<0.05, **p<0.01,
***p<0.001; two-tailed Student’s t test.
DOI: 10.7554/eLife.12242.003
The following figure supplement is available for figure 1:
Figure supplement 1. Chromatin Immunoprecipitation (ChIP) of ZF6-DB and ZF6-KRAB.
DOI: 10.7554/eLife.12242.004
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To test the functional activity of ZF6-DB in an adRP animal model, we used the RHO-P347S
mouse (Li et al., 1996), which harbors the P347S RHO human mutant allele including the 20 DNA
base pairs of the human genomic ZF6-cis sequence, whereas the murine Rho promoter sequence
lacks the ZF6-Cis target (Figure 1—figure supplement 1a) (Li et al., 1996). Therefore, human-spe-
cific P347S RHO silencing by ZF6-DB (which does not affect murine Rho expression) may result in
preservation of retinal function (Mussolino et al., 2011a). Strikingly, AAV8 vector delivery of ZF6-DB
resulted in significantly higher functional protection in both the A- and B-wave components of elec-
troretinography (ERG analysis) compared to ZF6-KRAB and AAV-GFP controls (Figure 3a). In addi-
tion, injection of either ZF6-KRAB or ZF6-DB in C57Bl/6 wild type retina did not produce detectable
functional detrimental effects (Figure 3b). Thus, the higher ERG responses observed in ZF6-DB-
compared to ZF6-KRAB-treated P347S mice should be further investigated.
To determine the therapeutic potential of DNA-binding-mediated silencing, we carried out the
silencing-replacement strategy (Kiang et al., 2005) by coupling ZF6-DB with RHO replacement
(human RHO, hRHO CDS) in order to complement Rho transcriptional repression in porcine retina
(Figure 4—figure supplement 1). To achieve simultaneous photoreceptor transduction of both ZF6-
DB and hRHO, we cloned the two expression cassettes into a single vector (DNA-binding repression
and replacement, DBR-R, construct; Figure 4a). The key variables to achieve highly differential
expression required for balanced simultaneous RHO repression and replacement are the vector
Figure 2. Photoreceptor delivery of ZF6-DB resulted in reduced genome-wide transcript perturbations. (a) RNA-Seq expression levels (Mean
Normalized Counts) comparison between 2 endogenous TFs (Crx and Nrl) and the expression levels resulting from transduction of AAV8-CMV-ZF6-DB
and AAV8-CMV-ZF6-KRAB, 15 days after retinal delivery (AAV8-CMV-ZF6-DB n= 6; AAV8-CMV-ZF6-KRAB n= 4 and 7 controls, non-transduced area). (b)
Rho and rod Gnat1 and Cone Arrestin 3 expression levels in treated and control retina. (c) Ingenuity Pathway Analysis of DEGs after ZF6-DB AAV
delivery in porcine retina showed a network of 13 genes. The 2 phototransduction genes RHO and GNAT1 are shown in green (down-regulated)
whereas the 2 genes associated with primary inflammatory response network, A2M and GFAP, are up-regulated (red). (d) Transcriptional activation and
repression concordances among Log Fold Changes of the genes in common (Swaroop et al., 2010) between ZF6-DB and ZF6-KRAB (Pearson
Correlation Test; PC=0.9787; p value << 1x10-5). (e) Venn Diagrams, pairwise intersection of the 2 sets of Differentially Expressed Genes (DEGs). An
adjusted p value (False Discovery Rate; FDR  0.1), without filtering on fold change levels, resulted in 19 and 222 DEGs, in ZF6-DBD and ZF6-KRAB
treated retina, respectively. The intersection resulted significant by hypergeometric test (p value << 1x10-5).
DOI: 10.7554/eLife.12242.005
The following figure supplements are available for figure 2:
Figure supplement 1. Ingenuity Pathway Analysis on DEGs of ZF6-KRAB treated retina.
DOI: 10.7554/eLife.12242.006
Figure supplement 2. Determination of the binding constants of ZF6-KRAB and ZF6-DB.
DOI: 10.7554/eLife.12242.007
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dose and promoter strength. Indeed, ZF6-DB (~200 counts; RNA-seq expression levels) generated a
decrease of about 100,000 Rho RNA-seq counts after transduction (~250,000 counts in controls vs.
~150,000 after treatment; Figure 2a,b). Thus, to ensure high and rod-specific hRHO replacement,
we opted for a high vector dose and the strength of the GNAT1 promoter (Figure 1h; [Lee et al.,
2010]). To decrease ZF6-DB expression levels at high vector dose, while keeping rod-specificity, we
both shortened the human RHO promoter and deleted the 5’ sequence of the ZF6-DB target ZF6-
Cis (Figure 4—figure supplement 2). We used 1x1012 gc of vector of DBR-R (AAV8-RHOD-ZF6-DB-
GNAT1-hRHO) to administer to porcine retina. As an internal control the contralateral eye received
the previously used ZF6-DB vector (AAV8-CMV-ZF6-DB; at 1x1010 gc; Figure 1). AAV8-CMV-eGFP
was co-administrated to label the transduced area. Administration of the DBR-R vector resulted in
rod-specific transcriptional repression of the porcine Rho (38%) and in concomitant replacement of
the exogenous hRHO (68%), as assessed by transcripts, protein expression levels, and integrity of
photoreceptor outer segments (Figure 4b–d and Figure 4—figure supplement 3). Notably, Gnat1
transcript and protein (data not shown) levels demonstrated complementation, supporting a second-
ary down-regulation of Gnat1 associated with Rho repression (Figure 4b).
In this study, we showed that photoreceptor genomic binding of a 20 bp-long DNA sequence by
a synthetic DNA-binding protein dramatically reduces Rho expression. The combination of Rho tran-
scriptional silencing and the restricted transcriptome perturbation induced by ZF6-DB, without the
intrinsic repression activity contained in an ED, indicate that the local binding to ZF6-cis per se is the
determinant of transcriptional repression, whereas the high specificity observed may result by both
Figure 3. ZF6-DB DNA-binding protein preserves retinal function of the P347S adRP mouse model. (a) Electroretinography (ERG) analysis on P347S
mice mice subretinally injected at post natal day 14 (PD14) with AAV8-CMV-ZF6-DB (n=10), AAV8-CMV-ZF6-KRAB (n=10), or AAV8-CMV-eGFP (n=10)
and analysed at P30. Retinal responses in both scotopic (dim light) and photopic (bright light) showed that both A- and B-waves amplitudes, evoked by
increasing light intensities, were preserved in both AAV8-CMV-ZF6-DB and ZF6-KRAB compared to eGFP control (b) A- and B-wave are shown for
injected C57Bl/6 mice with ZF6-DB (n=4), ZF6-KRAB (n=4) and eGFP (n=4), independently. No functional impairment is observed for each construct.
Error bars, means +/- s.e.m. *p<0.05, **p<0.01, ***p<0.001; two-tailed Student’s t test.
DOI: 10.7554/eLife.12242.008
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DNA-binding specificity (biochemical affinity) of ZF6-DB and the rod genomic context. The transcrip-
tional repression mechanism of ZF6-DB binding likely relies on the interference occurring between
TFs and local DNA sequence features within the RHO proximal promoter region (Mitton et al.,
2000), which we showed here to be necessary to control Rho expression at the genomic level. The
lack of known TFBSs and the low level of expression of ZF6-DB expressed in the photoreceptors,
which was twenty-fold below the levels of photoreceptor specific TFs (Crx and Nrl), suggest that the
molecular determinant of silencing may not be the simple displacement of key RHO TFs (Mao et al.,
2011). We propose a model in which the molecular features of the DNA (loop, twisting, bending, for
instance) may contribute to Rhodopsin transcriptional output. In this context, the DNA may be envis-
aged as not being exclusively the source of storage of functional information (protein coding and
non-coding transcripts) or an inert DNA-binding protein harbor (i.e. positional information for TFs
Figure 4. DNA-binding repression-replacement (DBR-R) of Rho in the porcine retina. (a) AAV8-RHOD-ZF6-DB-GNAT1-hRHO DBR-R construct features,
including the two expression cassettes, RHOD-ZF6-DB encoding for both the DNA-binding repressor ZF6-DB (orange), and GNAT1-hRHO for human
RHO for replacement (blue). The size (kb) of the construct is indicated as a bar. (b) qReal Time PCR, mRNA levels (2̂-DCT) 2 months after vector delivery
of either AAV8-CMV-ZF6-DB (DBR; orange bars) or AAV8-RHOD-ZF6-DB-GNAT1-hRHO (DBR-R, blue bars) and non-transduced controls (green bars).
pRho, porcine Rhodopsin; Gnat1, Guanine Nucleotide Binding Protein1; Arr3, Arrestin 3; hRHO, human Rhodopsin. The result is representative of two
independent experiments. Error bars, means +/- s.e.m. ; *p<0.05, **p<0.01, ***p<0.001; two-tailed Student’s t test. (c) Western blot analysis on the
retina showed in b, c and d. (d) Immunofluorescence double staining with Rho (green) and HA-ZF6-DB (red) antibodies. Left panel, non-transduced
control retina; middle panel, AAV8-CMV-ZF6-DB treated retina; left panel, AAV8-RHOD-ZF6-DB-GNAT1-hRHO DBR-R treated retina. OS, outer
segment; IS, inner segment; ONL, outer nuclear layer; INL, inner nuclear layer; scale bar, 100 mm.
DOI: 10.7554/eLife.12242.009
The following figure supplements are available for figure 4:
Figure supplement 1. Outline of the DNA-binding repressor-replacement (DBR-R) strategy.
DOI: 10.7554/eLife.12242.010
Figure supplement 2. Strength and tissue specificity of RHOD promoter elements in murine retina.
DOI: 10.7554/eLife.12242.011
Figure supplement 3. Cone morphological integrity after DNA-binding repression-replacement (DBR-R) subretinal delivery.
DOI: 10.7554/eLife.12242.012
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DNA binding), but also as an intrinsically active operator of the transcriptional function. This contri-
bution of DNA is supported by both the transcriptional repression upon the ZF6-cis deletion of 20
bp of DNA and intereference in trans by using a synthetic DNA binding protein that, not being
encoded by the genome, may occupy a protein-free portion of the genome. It follows that in terms
of signaling, the information source, the DNA, generates an output signal the RNA and eventually a
protein (TF), whose final output functional activity is completed back by the DNA. Thus the informa-
tion source, the DNA, becomes also integral part of the signaling (Rhodopsin transcriptional
output). In this vision, to act (interfere) upstream the DNA, an external function is necessary, which
is, in this study, the synthetic ZF6-DB carried by the vector.
From a therapeutic prospective, a relevant property of ZF6-DB DNA binding interference is the
high rate of transcriptional silencing observed after in vivo gene transfer, which is consistent with
canonical TFs mode of action (Kiang et al., 2005). DNA binding interference via ZF6-DB in trans-
duced retina generated 45% Rho transcriptional repression, which reached 85% when rods were
sorted, supporting its use for diseases requiring correction of a large number of affected cells, such
as adRP and other Mendelian disorders due to gain-of-function mutations. Furthermore, Rho tran-
scriptional silencing and its complete RHO replacement support in principle the use of the DBR-R
constructs for treatment of any RHO mutation including those caused by a dominant negative mech-
anism (Mao et al., 2011). However, the 38% silencing and replacement observed may not yet be
sufficient to achieve therapeutic efficacy/benefit in patients with adRP. Therefore, further develop-
ment of this proof-of-concept will include optimization of the design of the silencing and replace-
ment double construct (tuning the strength of the promoter elements), vector selection and dose,
and the surgical approach. In conclusion, in vivo retinal gene transfer of an AAV vector (Doria et al.,
2013; Liang et al., 2001; Scatchard, 1949) carrying a 22 kDa orthogonal (Surace et al., 2005) and
gene-extrinsic noise-resistant (the permissive rod photoreceptor cell-specific environment; [Li et al.,
2011]) synthetic protein acts as a transcriptional repressor, which results in a potent and specific
silencing of the Rho gene upon binding to an essential Rho DNA element.
Materials and methods
Plasmid construction
The ZF6-DNA-binding domain (ND96 deletion mutant, ZF6-DB) was amplified by PCR from AAV2.1
CMV-ZF6-KRAB (Mussolino et al., 2011a) using primers ZF6-DBfw (TTGCGGCCGCATGATCGATC
TGGAACCTGGCG) and ZF6-DBrv (AAGCTTTCAAGATGCATAGTCT). The PCR product was
digested using NotI and HindIII restriction enzymes and cloned in pAAV2.1. The hGNAT1 promoter
was synthetized by Eurofins MWG based on Lee et al. 2010 adding the 5’UTR. The fragment was
cloned in pAAV2.1 using NheI and NotI restriction enzymes. The human Rhodopsin CDS was ampli-
fied by PCR from human retina cDNA using the hRHOfw (GCGGCCGCATGAATGGCACA-
GAAGGCCC) e hRHOrv (AAGCTTTTAGGCCGGGGCCACCTG) primers and the PCR fragment was
digested using NotI and HindIII restriction enzymes and cloned in pAAV2.1 plasmid under the con-
trol of hGNAT1 promoter. The human rhodopsin short promoter (hRHO-short-(s), 164 bp from the
transcription starting site (TSS) + 5’UTR), the human rhodopsin long promoter (hRHO-long, 796 bp
from the TSS + 5’UTR), the human rhodopsin long promoter mutated of the ZF6-cis (hRHO-cis-del,
776 bp from the TSS lacking the bases -82 -62 from the TSS) and the human rhodopsin muted pro-
moter (hRHO-s-DZF6, lacking the bases -84 -77 from the TSS) were generated by gene synthesis of
Eurofins MWG and cloned in pAAV2.1 using NheI and NotI restriction enzymes. For the generation
of DBR-R plasmid the Eurofins MWG synthetized the expression cassette RHOD-ZF6-DB-bGHpolyA
(bovine growth hormone polyA) that we cloned in pAAV2.1 hGNAT1-hRHO using NheI restriction
enzyme.
AAV vector preparations
AAV vectors were produced by the TIGEM AAV Vector Core, by triple transfection of HEK293 cells
followed by two rounds of CsCl2 purification (Auricchio et al., 2001). For each viral preparation,
physical titers [genome copies (GC)/mL] were determined by averaging the titer achieved by dot-
blot analysis (Doria et al., 2013) and by PCR quantification using TaqMan (Applied Biosystems,
Carlsbad, CA, USA).
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Vector administration and animal models
All procedures were performed in accordance with institutional guidelines for animal research and
all of the animal studies were approved by the authors. P347S+/+ animals (Mussolino et al., 2011a;
Li et al., 1996) were bred in the animal facility of the Biotechnology Centre of the Cardarelli Hospital
(Naples, Italy) with C57Bl/6 mice (Charles Rivers Laboratories, Calco, Italy), to obtain the P347S+/-
mice.
Mice
Intraperitoneal injection of ketamine and medetomidine (100 mg/kg and 0.25 mg/kg respectively),
then AAV vectors were delivered sub-retinally via a trans-scleral transchoroidal approach as
described by Liang et al. (Liang et al., 2001).
Pigs
Eleven-week-old Large White (LW) female piglets were utilized. Pigs were fasted overnight leaving
water ad libitum. The anesthetic and surgical procedures for pigs were previously described
(Mussolino et al., 2011b). AAV vectors were inoculated sub-retinally in the avascular nasal area of
the posterior pole between the two main vascular arches, as performed in Mussolino et al.
(Mussolino et al., 2011b). This retinal region is crossed by a streak-like region that extends from the
nasal to the temporal edge parallel to the horizontal meridian, where cone density is high, reaching
20,000 to 35,000 cone cells mm2. Each viral vector was injected in a total volume of 100 ml, resulting
in the formation of a subretinal bleb with a typical ‘dome-shaped’ retinal detachment, with a size
corresponding to 5 optical discs.
Cloning and Purification of the proteins
DNA fragments encoding the sequence of the engineered transcription factors and ZF6-KRAB, to be
expressed as maltose-binding protein (MBP) fusion were generated by PCR using the plasmids
pAAV2.1 CMV-ZF6-KRAB and pAAV2.1 CMV-ZF6-DB as a DNA template. The following oligonucleo-
tides were used as primers: primer 1, (GGAATTCCATATGGAATTCCCCATGGATGC) and primer 2,
(CGGGATCCCTATCTAGAAGTCTTTTTACCGGTATG), for ZF6-KRAB primer 3, (GGAATTCCATA
TGCTGGAACCTGGCGAAAAACCG) and primer 4,(CGGGATCCCTATCTAGAAGTCTTTTTACCGG
TATG) for ZF6-DB. All the PCR products were digested with the restriction enzymes NdeI and
BamH1 and cloned into NdeI BamH1-digested pMal C5G (New England Biolabs, Ipswich, MA) bac-
terial expression vector. All the plasmids obtained were sequenced to confirm that there were no
mutations in the coding sequences. The fusion proteins were expressed in the Escherichia coli
BL21DE3 host strain. The transformed cells were grown in rich medium plus 0.2% glucose (according
to protocol from New England Biolabs) at 37˚C until the absorbance at 600 nm was 0.6–0.8, at which
time the medium was supplemented with 200 mM ZnSO4, and protein expression was induced with
0.3 mM isopropyl 1-thio-b-D-galactopyranoside and was allowed to proceed for 2 hr. The cells were
then harvested, resuspended in 1X PBS (pH 7.4), 1 mM phenylmethylsulfonyl fluoride, 1 mM leupep-
tin, 1 mM aprotinin, and 10 mg/ml lysozyme, sonicated, and centrifuged for 30 min at 27,500 relative
centrifugal force. The supernatant was then loaded on amylose resin (New England Biolabs) accord-
ing to the manufacturer’s protocol. To remove the MBP from the proteins, bound fusion proteins as
cleaved in situ on the amylose resin with Factor Xa (1 unit/20 mg of MBP fusion protein) in FXa buffer
(20 mM Tris, pH 8.0, 100 mM NaC1, 2 mM CaC12) for 24–48 hr at 4˚C and collected in the same
buffer after centrifugation at 500 relative centrifugal force for 5 min. The supernatant containing the
protein without the MBP tag was then recovered.
Gel mobility shift analysis
The affinity binding costant of proteins for hRHO proximal promoter sequence was measured by a
gel mobility shift assay by performing a titration of the proteins with the oligonucleotides. The puri-
fied proteins were incubated for 15 min on ice with hRHO 65 bp duplex oligonucleotide in the pres-
ence of 25 mM Hepes (pH 7.9), 50 mM KCl, 6.25 mM MgCl2, 1% Nonidet P-40, 5% glycerol. After
incubation, the mixture was loaded on a 5% polyacrylamide gel (29:1 acrylamide/bisacrylamide ratio)
and run in 0.5 TBE at 4˚C (200 V for 4 hr). Protein concentration was determined by a modified ver-
sion of the Bradford procedure. After electrophoresis, the gel was stained with the fluorescent dyes
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SYBR Green I Nucleic acid gel stain (Invitrogen, Carlsbad, CA) to visualize DNA. 2.5 mM of the ZF6-
KRAB protein was incubated with increasing concentrations (130, 135, 145, 150, 165, 170, 175, 180,
190, and 200 nM, respectively) of the duplex hRHO 65 bp, an apparent higher protein concentration
(2.5 mM) was required likely because not all the protein sample was correctly folded. In the case of
ZF6-DB, 1.5 mM of the protein was incubated with increasing concentrations (145, 150, 170, 175,
195, 210, 220, 225, 240, and 250 nM, respectively) of the duplex hRho 65 bp. Scatchard analysis of
the gel shift binding data was performed to obtain the Kd values (25). All numerical values were
obtained by computer quantification of the image using a Typhoon FLA 9500 biomolecular imager
(GE Healthcare Life Sciences).
qReal time PCR
RNAs from tissues were isolated using RNAeasy Mini Kit (Qiagen, Germany), according to the manu-
facturer protocol. cDNA was amplified from 1 mg isolated RNA using QuantiTect Reverse Transcrip-
tion Kit (Qiagen), as indicated in the manufacturer instructions.
The PCRs with cDNA were carried out in a total volume of 20 ml, using 10 ml LightCycler 480
SYBR Green I Master Mix (Roche, Switzerland) and 400 nM primers under the following conditions:
pre-Incubation, 50˚C for 5 min, cycling: 45 cycles of 95˚C for 10 s, 60˚C for 20 s and 72˚C for 20 s.
Each sample was analysed in duplicate in two-independent experiments. Transcript levels of pig reti-
nae were measured by quantitative Real Time PCR using the LightCycler 480 (Roche) and the follow-
ing primers: pRho_forward (ATCAACTTCCTCACGCTCTAC) and pRho_reverse (ATGAAGAGG
TCAGCCACTGCC), pGnat1_forward (TGTGGAAGGACTCGGGTATC) and pGnat1_reverse (GTC
TTGACACGTGAGCGTA), pArr3_forward (TGACAACTGCGAGAAACAGG) and pArr3_reverse
(CACAGGACACCATCAGGTTG). humanRho_forward (TCATGGTCCTAGGTGGCTTC), humanRho_r-
everse (ggaagttgctcatgggctta) and eGFP_forward (ACGTAAACGGCCACAAGTTC) and eGFP_re-
verse (AAGTCGTGCTGCTTCATGTG). All of the reactions were standardized against porcine Actb
using the following primers: Act_Forward (ACGGCATCGTCACCAACTG) and Act_reverse (CTGGG
TCATCTTCTCACGG).
Immunostaining
Frozen retinal sections were washed once with PBS and then fixed for 10 min in 4% PFA. Sections
were immerse in a retrieval solution (0,01 M citrate buffer, pH 6.0) and boiled three times in a micro-
wave. After the blocking solution (10% FBS, 10% NGS, 1% BSA) was added for 1 hr. The primary
antibody mouse anti-HA (1:300, Covance) was diluted in a blocking solution and incubated overnight
at 4˚C. The secondary antibody (Alexa FluorÒ 594, anti-mouse 1:1000, Molecular Probes, Invitrogen,
Carlsbad, CA) has been incubated for 1 hr. Vectashield (Vector Lab Inc., Peterborough, UK) was
used to visualize nuclei. Frozen retinal sections were permeabilized with 0.2% Triton X-100 and 1%
NGS for 1 hr, rinsed in PBS, blocked in 10% normal goat serum (NGS), and then incubated overnight
at 4˚C with rabbit human cone arrestin (hCAR) antibody, kindly provided by Dr. Cheryl M. Craft
(Doheny Eye Institute, Los Angeles, CA) diluted 1:10000 in 10% NGS. After three rinses with 0.1 M
PBS, sections were incubated in goat anti-rabbit IgG conjugated with Texas red (Alexa Fluor 594,
anti-rabbit 1:1000, Molecular Probes, Invitrogen, Carlsbad, CA) for 1 hr followed by three rinses with
PBS. Frozen retinal sections were permeabilized with 0.1% Triton X-100, rinsed in PBS, blocked in
20% normal goat serum (NGS), and then incubated overnight at 4˚C in a mouse anti-1D4 rhodopsin
antibody diluted 1:500 in 10% NGS. After three rinses with 0.1 M PBS, sections were incubated in
goat anti-mouse IgG conjugated with Texas red (Alexa FluorÒ 594, anti-mouse 1:1000, Molecular
Probes, Invitrogen, Carlsbad, CA) for 1 hr followed by other three rinses with PBS. Sections were
photographed using either a Zeiss 700 Confocal Microscope (Carl Zeiss, Oberkochen, Germany) or a
Leica Fluorescence Microscope System (Leica Microsystems GmbH, Wetzlar, Germany). Triple-immu-
nostaining for anti-HA, anti-GNAT1, and anti-Rhodopsin antibody. Frozen retinal sections were
washed once with PBS and then fixed for 10 min in 4% PFA. Sections were immerse in a retrieval
solution (0,01 M sodium citrate buffer, pH 6.0) and boiled three times in a microwave. After the
blocking solution (10% FBS, 10% NGS, 1% BSA) was added for 1 hr. The two primary antibody
mouse anti-HA (1:300, Covance) and rabbit GaT1 (Santacruz Biotechnology), were diluted in a block-
ing solution and incubated overnight at 4˚C. The secondary antibodies (Alexa Fluor 594, anti-mouse
1:800, Molecular Probes, and Alexa Fluor 488, anti-rabbit 1:500, Molecular Probes, Invitrogen,
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Carlsbad, CA) have been incubated for 1 hr, followed by three rinses with PBS. After the slides were
incubated in blocking solution (10% NGS) for 1 hr and then incubated O.N. with primary antibody
mouse- 1D4 (1:500, Abcam). The secondary antibodies (Alexa Fluor 405, anti-mouse 1:200, Molecu-
lar Probes, Invitrogen). Sections were photographed using a Leica Fluorescence Microscope System
(Leica Microsystems GmbH, Wetzlar, Germany).
Western blot analyses
Western blot analysis was performed on retinae, which were harvested. Samples were lysed in hypo-
tonic buffer (10 mM Tris-HCl [pH 7.5], 10 mM NaCl, 1,5 mM MgCl2, 1% CHAPS, 1 mM PMSF, and
protease inhibitors) and 20 mg of these lysates were separated by 12% SDS-PAGE. After the blots
were obtained, specific proteins were labeled with anti-1D4 antibody anti-Rhodopsin-1D4 (1:1000;
Abcam, Cambridge, MA), and anti-b-tubulin (1:10000; Sigma-Aldrich, Milan, Italy) antibodies.
Chromatin immunoprecipitation experiments (ChIP)
For ChIP experiments, HEK293 cells were transfected by CaCl2 with pAAV2.1 CMV-ZF6-KRAB,
pAAV2.1 CMV-ZF6-DB or pAAV2.1 CMV-eGFP. The cells are harvested after 48 hr. ChIP was per-
formed as follow: cells were homogenized mechanically and cross linked using 1% formaldehyde in
PBS at room temperature for 10 min, then quenched by adding glycine at final concentration
125 mM and incubated at room temperature for 5 min. Cells were washed three times in cold PBS
1X then cells were lysed in cell lysis buffer (Pipes 5 mM pH 8.0, Igepal 0.5%, KCl 85 mM) for 15 min.
Nuclei were lysed in nuclei lysis buffer (Tris HCl pH8.0 50 mM, EDTA 10 mM, SDS 0.8% ) for 30 min.
Chromatin was shared using Covaris s220. The shared chromatin was immunoprecipitated over night
with anti HA ChIP grade (Abcam, ab 9110, Cambridge, MA). The immunoprecipitated chromatin
was incubated 3 hr with magnetic protein A/G beads (Invitrogen, Carlsbad, CA). Beads were than
washed with wash buffers and DNA eluted in elution buffer (Tris HCl pH 8 50 mM, EDTA 1 mM, SDS
1%). Then Real Time PCR was performed using primers on rhodopsin TSS, hRHOTSSFw (TGACC
TCAGGCTTCCTCCTA) and hRHOTSSRv (ATCAGCATCTGGGAGATTGG), trasducin 1 TSS,
hGNAT1TSSFw (CAGCCCTGACCCTACTGAAC) and hGNAT1TSSRv (CAACCGCTGACTCTGCACT),
arrestin 3 TSS, hArr3TssFw (CCTGCTGTGCACATAAGCTG) and hArr3TssRv (CGTGTCCCACTCCAA
TCTCT), and b-tubulin TSS, hTUBTSSFw (TCCTGTACCCCCAAGAACTG) and hTUBTSSRv (GC
TGCAAAATGAAGTGACGA).
FACS rods sorting
Co-injected porcine retina with AAV8-CMV-ZF6-DB (dose 5x1010 gc)and AAV8-GNAT1-eGFP (dose
1x1012 gc) were disaggregated using Papain Dissociation System (Worthington biochemical corpora-
tion) following the manufacturers protocol. Dissociated retinal cells were analysed using BD FACSA-
ria at IGB (Institute of Genetic and Biophysic “A. Buzzati-Traverso”) FACS Facility and sorted,
dividing eGFP positive cells (rods) from eGFP negative fraction.
Electrophysiological testing
The method is as described (Surace et al., 2005). Brifley, mice were dark reared for 3 hr and anes-
thetized. Flash electroretinograms (ERGs) were evoked by 10-ms light flashes generated through a
Ganzfeld stimulator (CSO, Costruzione Strumenti Oftalmici, Florence, Italy) and registered as previ-
ously described. ERGs and b-wave thresholds were assessed using the following protocol. Eyes were
stimulated with light flashes increasing from  5.2 to +1.3 log cd*s/m2 (which correspond to
110 5.2 to 20.0 cd*s/m2) in scotopic conditions. The log unit interval between stimuli was 0.3 log
from  5.4 to 0.0 log cd*s/m2, and 0.6 log from 0.0 to +1.3 log cd*s/m2. For ERG analysis in scotopic
conditions the responses evoked by 11 stimuli (from  4 to +1.3 log cd*s/m2) with an interval of 0.6
log unit were considered. To minimize the noise, three ERG responses were averaged at each 0.6
log unit stimulus from  4 to 0.0 log cd*s/m2 while one ERG response was considered for higher
(0.0 +1.3 log cd*s/m2) stimuli. The time interval between stimuli was 10 s from  5.4 to 0.7 log
cd*s/m2, 30 s from 0.7 to +1 log cd*s/m2, or 120 s from +1 to +1.3 log cd*s/m2. a- and b-waves
amplitudes recorded in scotopic conditions were plotted as a function of increasing light intensity
(from  4 to +1.3 log cd*s/m2, Figure 3). The photopic ERG was recorded after the scotopic session
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by stimulating the eye with ten 10 ms flashes of 20.0 cd*s/m2 over a constant background illumina-
tion of 50 cd/m2.
RNASeq library preparation, sequencing and alignment
The 17 libraries were prepared using the TruSeq RNA v2 Kit (Illumina, San Diego, CA) according to
manufacturer’s protocol. Libraries were sequenced on the Illumina HiSeq 1000 platform and in 100-
nt paired-end format to obtain approximately 30 million read pairs per sample. Sequence Reads
were trimmed using Trim Galore! software (v.0.3.3), that trims low-quality ends and removes adapter
from reads, using a Default Phred score of 20. To obtain a precise estimation of this yet uncharacter-
ized tissue, the 17 libraries were aligned against the full transcriptome for Sus scrofa (Pig) as pro-
vided by ENSEMBL (SusScrofa 10.2.73). The GTF included the sequences for the 20 canonical
chromosomes plus 4563 scaffolds, and counted 30.567 transcripts plus the sequences for the 3 exo-
genes used in the analysis (the 2 TRs and eGFP). Alignment was performed with RSEM (v.1.2.11)
(Li et al., 2011) with default parameters. The resulting expected counts (the sum of the posterior
probability of each read coming from a specific transcript over all reads) were used for subsequent
analysis.
Differential expression analysis
The dataset was composed of 17 samples and 25.325 genes, divided in 3 experimental groups: 7
Controls, 4 ZF6-KRAB-treated, 6 ZF6-DB-treated.
We analyzed the data following the standard Differential Expression Analysis Pipeline with
DESeq2 R/Bioconductor package (v.1.8.1) (Love et al., 2014), filtering and normalizing all libraries
together. We filtered low tag counts retaining those which had 1 CPM in at least 3 samples.
We fitted a unique Generalized Linear Model (GLM) with 1 factor and 3 levels (Control, ZF6-
KRAB-treated, ZF6-DB-treated). Differentially expressed genes were obtained out of the 2 contrasts
(each treatment compared to the controls), an adjusted pvalue (FDR) of less than or equal to 0.1 was
considered significant. We observed the expected upregulation of the exogenous genes used for
the treatment (ZF6-KRAB, ZF6-DB, eGFP) and for further evaluations we didn’t take into account
their differential expression.
Functional concordance
The 16 genes in common between the ZF6-DB and ZF6-KRAB DEGs were tested for functional con-
cordance using Pearson product moment correlation coefficient (cor.test, R package stats v.3.2.0)
(Huber et al., 2015; R Core Team, 2015).
Two named numeric vectors, one for each condition, containing the Log fold changes values of
the 16 genes were tested for association with cor.test default function, method = ’Pearson’.
Heatmap
A manually curated list of Human Gene IDs including representative Retinal Markes and a subset of
Retina Disease Genes (Daiger BR et al., 1998) was used to show the interference power of the 2
TRs with the overall regulatory circuitry. The Human IDs were used to retrieve their homolog Porcine
genes, if present. Genes with duplicated homolog in the Sus scrofa genome were included in the list
(genes tagged with_1 in Figure 2).
Data management
All the analyses, except for the reads quality filtering, alignment and expression estimates, were per-
formed in the R statistical environment (v.3.2.0) (Huber et al., 2015; R Core Team, 2015). Plots
were generated with ggplot2 R/Bioconductor package (v.1.0.1) (Wickham, 2009).
Statistical analyses
Data are presented as mean ± Error bars indicate standard error mean (SEM). Statistical significance
was computed using the Student’s two-sided t-test and p-values <0.05 were considered significant.
No statistical methods were used to estimate the sample size and no animals were excluded.
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Pagès H, Reyes A, Shannon P, Smyth GK, Tenenbaum D, Waldron L, Morgan M. 2015. Orchestrating high-
throughput genomic analysis with bioconductor. Nature Methods 12:115–121. doi: 10.1038/nmeth.3252
Botta et al. eLife 2016;5:e12242. DOI: 10.7554/eLife.12242 13 of 14
Short report Human biology and medicine Neuroscience
Kadonaga JT. 2004. Regulation of RNA polymerase II transcription by sequence-specific DNA binding factors.
Cell 116:247–257. doi: 10.1016/S0092-8674(03)01078-X
Kiang AS, Palfi A, Ader M, Kenna PF, Millington-Ward S, Clark G, Kennan A, O’reilly M, Tam LC, Aherne A,
McNally N, Humphries P, Farrar GJ. 2005. Toward a gene therapy for dominant disease: validation of an RNA
interference-based mutation-independent approach. Molecular Therapy 12:555–561. doi: 10.1016/j.ymthe.
2005.03.028
Konermann S, Brigham MD, Trevino A, Hsu PD, Heidenreich M, Cong L, Platt RJ, Scott DA, Church GM, Zhang
F. 2013. Optical control of mammalian endogenous transcription and epigenetic states. Nature 500:472–476.
doi: 10.1038/nature12466
Kwasnieski JC, Mogno I, Myers CA, Corbo JC, Cohen BA. 2012. Complex effects of nucleotide variants in a
mammalian cis-regulatory element. Proceedings of the National Academy of Sciences of the United States of
America 109:19498–19503. doi: 10.1073/pnas.1210678109
Lee J, Myers CA, Williams N, Abdelaziz M, Corbo JC. 2010. Quantitative fine-tuning of photoreceptor cis-
regulatory elements through affinity modulation of transcription factor binding sites. Gene Therapy 17:1390–
1399. doi: 10.1038/gt.2010.77
Li B, Dewey CN, RSEM DC. 2011. RSEM: accurate transcript quantification from RNA-seq data with or without a
reference genome. BMC Bioinformatics 12:323. doi: 10.1186/1471-2105-12-323
Li T, Snyder WK, Olsson JE, Dryja TP. 1996. Transgenic mice carrying the dominant rhodopsin mutation P347S:
evidence for defective vectorial transport of rhodopsin to the outer segments. Proceedings of the National
Academy of Sciences of the United States of America 93:14176–14181. doi: 10.1073/pnas.93.24.14176
Liang FQ, Anand V, Maguire AM, Bennett J. 2001. Intraocular delivery of recombinant virus. Methods in
Molecular Medicine 47:125–139. doi: 10.1385/1-59259-085-3:125
Love MI, Huber W, Anders S. 2014. Moderated estimation of fold change and dispersion for RNA-seq data with
DESeq2. Genome Biology 15:550. doi: 10.1186/s13059-014-0550-8
Malik S, Roeder RG. 2010. The metazoan mediator co-activator complex as an integrative hub for transcriptional
regulation. Nature Reviews Genetics 11:761–772. doi: 10.1038/nrg2901
Mao H, James T, Schwein A, Shabashvili AE, Hauswirth WW, Gorbatyuk MS, Lewin AS. 2011. AAV delivery of
wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa.
Human Gene Therapy 22:567–575. doi: 10.1089/hum.2010.140
Mitton KP, Swain PK, Chen S, Xu S, Zack DJ, Swaroop A. 2000. The leucine zipper of NRL interacts with the CRX
homeodomain: a possible mechanism of transcriptional synergy in rhodopsin regulation. Journal of Biological
Chemistry 275:29794–29799. doi: 10.1074/jbc.M003658200
Mussolino C, Sanges D, Marrocco E, Bonetti C, Di Vicino U, Marigo V, Auricchio A, Meroni G, Surace EM. 2011a.
Zinc-finger-based transcriptional repression of rhodopsin in a model of dominant retinitis pigmentosa. EMBO
Molecular Medicine 3:118–128. doi: 10.1002/emmm.201000119
Mussolino C, della Corte M, Rossi S, Viola F, Di Vicino U, Marrocco E, Neglia S, Doria M, Testa F, Giovannoni R,
Crasta M, Giunti M, Villani E, Lavitrano M, Bacci ML, Ratiglia R, Simonelli F, Auricchio A, Surace EM. 2011b.
AAV-mediated photoreceptor transduction of the pig cone-enriched retina. Gene Therapy 18:637–645. doi: 10.
1038/gt.2011.3
Neph S, Stergachis AB, Reynolds A, Sandstrom R, Borenstein E, Stamatoyannopoulos JA. 2012. Circuitry and
dynamics of human transcription factor regulatory networks. Cell 150:1274–1286. doi: 10.1016/j.cell.2012.04.
040
Palczewski K. 2012. Chemistry and biology of vision. Journal of Biological Chemistry 287:1612–1619. doi: 10.
1074/jbc.R111.301150
Pavletich N, Pabo C. 1991. Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 a.
Science 252:809–817. doi: 10.1126/science.2028256
Perissi V, Jepsen K, Glass CK, Rosenfeld MG, repression D. 2010. Deconstructing repression: evolving models of
co-repressor action. Nature Reviews Genetics 11:109–123. doi: 10.1038/nrg2736
Ptashne M. 2014. The chemistry of regulation of genes and other things. Journal of Biological Chemistry 289:
5417–5435. doi: 10.1074/jbc.X114.547323
R Core Team. 2015. R: A Language and Environment for Statistical Computing. Austria, Vienna: R Foundation for
Statistical Computing. http://www.R-project.org/.
Roger JE, Hiriyanna A, Gotoh N, Hao H, Cheng DF, Ratnapriya R, Kautzmann M-AI, Chang B, Swaroop A. 2014.
OTX2 loss causes rod differentiation defect in CRX-associated congenital blindness. Journal of Clinical
Investigation 124:631–643. doi: 10.1172/JCI72722
Scatchard G. 1949. The attractions of proteins for small molecules and ions. Annals of the New York Academy of
Sciences 51:660–672. doi: 10.1111/j.1749-6632.1949.tb27297.x
Surace EM, Domenici L, Cortese K, Cotugno G, Di Vicino U, Venturi C, Cellerino A, Marigo V, Tacchetti C,
Ballabio A, Auricchio A. 2005. Amelioration of both functional and morphological abnormalities in the retina of
a mouse model of ocular albinism following AAV-mediated gene transfer. Molecular Therapy 12:652–658. doi:
10.1016/j.ymthe.2005.06.001
Swaroop A, Kim D, Forrest D. 2010. Transcriptional regulation of photoreceptor development and homeostasis
in the mammalian retina. Nature Reviews Neuroscience 11:563–576. doi: 10.1038/nrn2880
Wickham H. 2009. Ggplot2: elegant graphics for data analysis: Springer Science & Business Media. New York,
NY: Springer New York. doi: 10.1007/978-0-387-98141-3
Botta et al. eLife 2016;5:e12242. DOI: 10.7554/eLife.12242 14 of 14
Short report Human biology and medicine Neuroscience
